MediValve Vascular Device Trial

Posted in: Articles  |  November 3, 2014 at 6:38 pm
Comments are closed
MediValve, Ltd., a Trendlines portfolio company, announced that it has successfully completed the first two cases of post-market clinical evaluation of its acWire Guidewire[1],[2],[3]. The acWire is intended for use in peripheral vascular and heart catheterization procedures to introduce and assist in positioning diagnostic and interventional devices. The acWire may also function as an alignment tool by providing a reference plane of anatomical structure of interest (i.e., the aortic valve). The acWire has received FDA 510(k) pre-market clearance as well as CE pre-market clearance.

Written by

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Etiam libero diam, elementum eget porttitor at, tincidunt at nulla.